<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 3875         </title>
<shortdesc>INC TX-INNOVATION CREDIT</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Ram Villivalam-Donald P. DeWitte-Melinda Bush, David Koehler and Jason A. Barickman</sponsors>
</sponsor>
<lastaction>
<statusdate>1/13/2021</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>35 ILCS 5/201</reference><aliasreference></aliasreference><SynopsisText>Amends the Illinois Income Tax Act. Provides that a taxpayer shall be allowed an income tax credit in an amount equal to 1.3% of the qualified research expenses made by the taxpayer in Illinois. Provides that the taxpayer is not required to have obtained a research and development credit with respect to his or her federal income taxes to qualify for the Illinois research and development credit.</SynopsisText></synopsis>
<actions>
<statusdate>2/14/2020</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Ram Villivalam</action>
<statusdate>2/14/2020</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/14/2020</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>2/18/2020</statusdate><chamber>Senate</chamber><action>Added as Chief Co-Sponsor Sen. Donald P. DeWitte</action>
<statusdate>2/25/2020</statusdate><chamber>Senate</chamber><action>Added as Chief Co-Sponsor Sen. Melinda Bush</action>
<statusdate>2/27/2020</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. David Koehler</action>
<statusdate>3/3/2020</statusdate><chamber>Senate</chamber><action>Added as Co-Sponsor Sen. Jason A. Barickman</action>
<statusdate>3/12/2020</statusdate><chamber>Senate</chamber><action>Assigned to Revenue</action>
<statusdate>3/18/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As April 2, 2020</action>
<statusdate>3/25/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As April 24, 2020</action>
<statusdate>3/25/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 7, 2020</action>
<statusdate>4/12/2020</statusdate><chamber>Senate</chamber><action>Pursuant to Senate Rule 3-9(b) / Referred to Assignments</action>
<statusdate>4/16/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As April 30, 2020</action>
<statusdate>4/23/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As May 7, 2020</action>
<statusdate>4/23/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 15, 2020</action>
<statusdate>4/30/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As May 15, 2020</action>
<statusdate>4/30/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 22, 2020</action>
<statusdate>5/7/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As May 22, 2020</action>
<statusdate>5/7/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 29, 2020</action>
<statusdate>5/15/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020</action>
<statusdate>1/13/2021</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</actions>
</xml>

